Observational studyBiochemical pharmacology2021

Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

Lorena Vigón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.